Association of TLR and TREM-1 gene polymorphisms with atherosclerosis severity in a Russian population

Meta Gene

Volumn 9, Issue , 2016, Pages 76-89

  Kutikhin, Anton G ^a   Ponasenko, Anastasia V ^a   Khutornaya, Maria V ^a   Yuzhalin, Arseniy E ^b   Zhidkova, Irina I ^a   Salakhov, Ramil R ^a   Golovkin, Alexey S ^a   Barbarash, Olga L ^a   Barbarash, Leonid S ^a  

^a RESEARCH INSTITUTE FOR COMPLEX ISSUES OF CARDIOVASCULAR DISEASES   (Russian Federation)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atherosclerosis; Coronary artery disease; Gene polymorphisms; Toll like receptors; Triggering receptor expressed on myeloid cells 1

Indexed keywords

TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84965022486     PISSN: None     EISSN: 22145400     Source Type: Journal    
DOI: 10.1016/j.mgene.2016.04.001     Document Type: Article

References (34)

1. Ammirati E., Moroni F., Magnoni M., Camici P.G. The role of T and B cells in human atherosclerosis and atherothrombosis. Clin. Exp. Immunol. 2015, 179:173-187.
2. Bakhtiar S.M., Ali A., Baig S.M., Barh D., Miyoshi A., Azevedo V. Identifying human disease genes: advances in molecular genetics and computational approaches. Genet. Mol. Res. 2014, 13:5073-5087.
3. Bentzon J.F., Otsuka F., Virmani R., Falk E. Mechanisms of plaque formation and rupture. Circ. Res. 2014, 114:1852-1866.
4. Berg K.K., Madsen H.O., Garred P., Wiseth R., Gunnes S., Videm V. The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand. J. Immunol. 2009, 69:36-42.
5. Boekholdt S.M., Agema W.R., Peters R.J., Zwinderman A.H., van der Wall E.E., Reitsma P.H., et al. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 2003, 107:2416-2421.
6. Chen Q., Zhou H., Wu S., Wang H., Lv C., Cheng B., et al. Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population. Hum. Immunol. 2008, 69:220-226.
7. Dayem Ullah A.Z., Lemoine N.R., Chelala C. SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update). Nucleic Acids Res. 2012, 40. (Web Server issue):W65-70.
8. Eguchi K., Manabe I. Toll-like receptor, lipotoxicity and chronic inflammation: the pathological link between obesity and cardiometabolic disease. J. Atheroscler. Thromb. 2014, 21:629-639.
9. Fihn S.D., Blankenship J.C., Alexander K.P., Bittl J.A., Byrne J.G., Fletcher B.J., et al. ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2014, 130:1749-1767. (2014).
10. Golovkin A.S., Ponasenko A.V., Khutornaya M.V., Kutikhin A.G., Salakhov R.R., Yuzhalin A.E., et al. Association of TLR and TREM-1 gene polymorphisms with risk of coronary artery disease in a Russian population. Gene 2014, 550:101-109.
11. Golovkin A.S., Ponasenko A.V., Yuzhalin A.E., Salakhov R.R., Khutornaya M.V., Kutikhin A.G., et al. An association between single nucleotide polymorphisms within TLR and TREM-1 genes and infective endocarditis. Cytokine 2015, 71:16-21.
12. Guven M., Ismailoglu Z., Batar B., Unal S., Onaran I., Karadag B., et al. The effect of genetic polymorphisms of TLR2 and TLR4 in Turkish patients with coronary artery disease. Gene 2015, 558:99-102.
13. Hamann L., Koch A., Sur S., Hoefer N., Glaeser C., Schulz S., et al. Association of a common TLR-6 polymorphism with coronary artery disease - implications for healthy ageing?. Immun. Ageing 2013, 10:43.
14. Hernesniemi J., Lehtimäki T., Rontu R., Islam M.S., Eklund C., Mikkelsson J., et al. Toll-like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions. Scand. J. Clin. Lab. Invest. 2006, 66:667-675.
15. Hernesniemi J.A., Raitakari O.T., Kähönen M., Juonala M., Hutri-Kähönen N., Marniemi J., et al. Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study. Atherosclerosis 2008, 198:152-159.
16. Hommels M.J., Kroon A.A., Netea M.G., de Leeuw P.W., Bruggeman C.A., Leiner T., et al. The Asp299Gly Toll-like receptor 4 polymorphism in advanced aortic atherosclerosis. Neth J. Med. 2007, 65:203-207.
17. Jung E.S., Kim S.W., Moon C.M., Shin D.J., Son N.H., Kim E.S., et al. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population. Life Sci. 2011, 89:289-294.
18. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 2002, 347:185-192.
19. Labrum R., Bevan S., Sitzer M., Lorenz M., Markus H.S. Toll receptor polymorphisms and carotid artery intima-media thickness. Stroke 2007, 38:1179-1184.
20. Mandal K., Afzal A.R., Brecker S.J., Poloniecki J., Xu Q., Jahangiri M. Association of serum soluble heat shock protein 60 with toll-like receptor 4 polymorphism and severity of coronary artery disease. Heart 2006, 92:683-685.
21. Manolakis A.C., Kapsoritakis A.N., Tiaka E.K., Sidiropoulos A., Gerovassili A., Satra M., et al. TLR4 gene polymorphisms: evidence for protection against type 2 diabetes but not for diabetes-associated ischaemic heart disease. Eur. J. Endocrinol. 2011, 165:261-267.
22. Netea M.G., Hijmans A., van Wissen S., Smilde T.J., Trip M.D., Kullberg B.J., et al. Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur. J. Clin. Investig. 2004, 34:94-99.
23. Norata G.D., Garlaschelli K., Ongari M., Raselli S., Grigore L., Benvenuto F., et al. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J. Intern. Med. 2005, 258:21-27.
24. Pelham C.J., Agrawal D.K. Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases. Expert. Rev. Clin. Immunol. 2014, 10:243-256.
25. Rivera-Chávez F.A., Huebinger R.M., Burris A., Liu M.M., Minei J.P., Hunt J.L., et al. A TREM-1 polymorphism A/T within the Exon 2 is associated with pneumonia in burn-injured patients. ISRN Inflamm 2013, 2013:431739.
26. Shah P.K., Chyu K.Y., Dimayuga P.C., Nilsson J. Vaccine for atherosclerosis. J. Am. Coll. Cardiol. 2014, 64:2779-2791.
27. Sianos G., Morel M.A., Kappetein A.P., Morice M.C., Colombo A., Dawkins K., et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005, 1:219-227.
28. Solé X., Guinó E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
29. Su L., Liu C., Li C., Jiang Z., Xiao K., Zhang X., et al. Dynamic changes in serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and its gene polymorphisms are associated with sepsis prognosis. Inflammation 2012, 35:1833-1843.
30. Vainas T., Stassen F.R., Bruggeman C.A., Welten R.J., van den Akker L.H., Kitslaar P.J., et al. Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease. J. Vasc. Surg. 2006, 44:326-332.
31. Xu Z., Taylor J.A. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009, 37. (Web Server issue):W600-5.
32. Yang I.A., Holloway J.W., Ye S., Southampton Atherosclerosis Study (SAS) Group TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis 2003, 170:187-190.
33. Yuzhalin A.E., Kutikhin A.G. Integrative systems of genomic risk markers for cancer and other diseases: future of predictive medicine. Cancer Manag. Res. 2012, 4:131-135.
34. Zhang K., Zhang L., Zhou B., Wang Y., Song Y., Rao L., et al. Lack of association between TLR4 Asp299Gly polymorphism and atherosclerosis: evidence from meta-analysis. Thromb. Res. 2012, 130:e203-e208.